Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has reported beneficial ownership of 5.03% of Ceribell Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.6% in ChargePoint Holdings Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.5% of Charter Communications, Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.9% in Clear Channel Outdoor Holdings Inc. as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.7% in Context Therapeutics Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.6% in California Bancorp's common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.4% in Credicorp Ltd. common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.3% of Bitdeer Technologies Group's Class A Stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.9% beneficial ownership of American Public Education Inc. common stock as of June 30, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 33,451,608 shares of Cushman & Wakefield Ltd. common stock, representing 14.3% of the class.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7,987,262 shares, representing 8.3% of the outstanding common stock of CRISPR Therapeutics AG.

BlackRock, Inc. has disclosed beneficial ownership of 5.4% of ADC Therapeutics SA's common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.4% of Caledonia Mining Corporation PLC's common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.4% of Ardmore Shipping Corporation's common stock as of June 30, 2026.

BlackRock, Inc. has updated its beneficial ownership filing for Adobe Inc., reporting a 9.4% stake as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.6% in Aemetis Inc. as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.3% of AELUMA INC's common stock as of June 30, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 7.4% of Amprius Technologies Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.3% of Enviri Corp's common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting no beneficial ownership of ENVIRI LLC's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 12.6% of DENTSPLY SIRONA INC's common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 10.1% of Exelon Corporation's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed beneficial ownership of 2,194,284 shares, representing 1.9% of the outstanding common stock of Fate Therapeutics Inc., as of June 30, 2026.

BlackRock, Inc. has disclosed beneficial ownership of 2,290,077 shares, representing 2.7% of the outstanding common stock of JELD WEN Holding Inc., as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 13.0% of Nicolet Bankshares Inc. common stock as of June 30, 2026.

BlackRock, Inc. has disclosed beneficial ownership of 8.2% of Universal Health Realty Income Trust's common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 12.3% of Ashland Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 12.6% of Astronics Corp's Class B Stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 11.3% of Boston Beer Co. Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 11.7% of Coeur Mining, Inc.'s common stock as of June 30, 2026.